Activated T cells are also detected by nucleic acid probes directed to messenger RNA encoding the H400 protein.BROWN, KEITH D.MOSMANN, TIMOTHY R.ZURAWSKI, GERALDZURAWSKI, SANDRA M.
markers of t cell activation. 来自 掌桥科研 喜欢 0 阅读量: 4 申请(专利)号: DE19896005633T 申请日期: 1989-02-13 公开/公告号: DE68905633D1 公开/公告日期: 1993-05-06 申请(专利权)人: SCHERING BIOTECH CORP., PALO ALTO, CALIF., US 发明人: BROWN, KEITH D., HUNTERS HILL NEW ...
Gregorio G. Aversa and Bruce M. HallTransplantation ReviewsAversa, GGaH & Bruce, M. Cell Surface Markers of T-Cell Activation. Transplant Rev. 5, 22 (1991).Aversa, G. G., and B. M. Hall. 1991. Cell surface markers of T-cell activation. Transplant. Rev. 5:9-21....
We have, therefore, expanded our earlier work by using a panel of different T cell activation markers (CD25, CD26, CD40L, CD69). The study is based on 58 culprit lesions from patients who underwent coronary atherectomy. There were four groups of patients: chronic stable angina ( n=13)...
The differentiation of T cells toward a senescent phenotype is characterized typically by clonal expansion of CD8+ T lymphocytes that lack expression of CD28.8,9 CD28 is an important co-stimulatory molecule for T-cell activation, and a marker of the proliferative history of cells. Low expression ...
They can also play a major role in the development and persistence of some autoimmune diseases. Some of the key effects of IL-17 production include the induction of neutrophil activation and the production of antimicrobial substances by a number of cell types. Other Activated CD4+ T Cells Th1,...
immune response, since a large variety of bacteria and viruses can lead to the activation of NFκB, which in turn controls the expression of many inflammatory cytokines, chemokines, immune receptors, and cell surface adhesion molecules. ... X Li,GR Stark - 《Experimental Hematology》 被引量: ...
Simple Plex assays on the Ella platform offer a rapid and precise assessment of secreted T cell activation markers.
Immune activation markers and CD4+ T-cell counts in HIV-infected intravenous drug users. J Acquir Immune Defic Syndr (1992) 5:1273-4. doi:10.1097/... R Zangerle,H Wachter,D Fuchs - 《Journal of Acquired Immune Deficiency Syndromes》 ...
Analysis of the pivotal phase 3 ZUMA-7 trial identifies tumor gene expression signatures that are uniquely predictive of anti-CD19 CAR T cell response and event-free survival in second-line treatment for patients with relapsed or refractory large B cell lymphoma. Frederick L. Locke , Simone ...